Chief Executive Officer
IHH Healthcare Malaysia

Dr Kamal Amzan was appointed the Acting Chief Executive Officer of IHH Healthcare Malaysia on 1 August 2025. He provides strategic leadership and ensures high standards of operational and clinical excellence across IHHʼs integrated healthcare network in Malaysia. This includes a network of 18 hospitals encompassing Gleneagles Hospitals, Island Hospital, Pantai Hospitals, Prince Court Medical Centre and Timberland Medical Centre, as well as ancillary services such as Premier Integrated Labs and Premier Integrated Rehab.

With over a decade at IHH Malaysia, Dr Kamal has held multiple senior leadership positions including Regional CEO for Southern and Eastern Malaysia, Chief Executive Officer of Gleneagles Hospital Johor, Chief Operating Officer of Gleneagles Hospital Kuala Lumpur and Pantai Hospital Batu Pahat and Head of Medical Affairs and Quality for IHH Malaysia. He has distinguished himself not only in operational roles but also in clinical quality, and system-wide performance across the healthcare sector.

Dr Kamal also serves on the board of the Association of Private Hospitals Malaysia and is an active voice in forums and on social media, championing better healthcare access and quality by combining visionary goals with pragmatic solutions to drive meaningful change.

Group Chief Medical Officer
IHH Healthcare

As Group Chief Medical Officer at IHH Healthcare, Adjunct Associate Professor (Adj Assoc. Prof) Keith Lim oversees clinical quality, patient safety, and value-based care across the group, setting policies and driving quality improvements, to ensure patients receive world-class and cost-effective care.

With over 20 years of experience as a radiation oncologist, Adj Assoc. Prof Lim has made significant academic contributions, previously serving as Assistant Dean at the NUS School of Medicine. His research has been cited over 2000 times, and he has secured over S$2.5 million in research funding.

Prior to IHH, he was Group Chief Value Officer at NUHS, pioneering Singaporeʼs value-based healthcare programme and leading efforts to optimise clinical and financial outcomes. He also served as Director of Clinical Outcomes and Value at Singaporeʼs Ministry of Health, where he set clinical standards and implemented value-driven care across public hospitals. His contributions have earned him Singaporeʼs National Medical Excellence Award, the highest medical honour in the country.

Founder & Chief Executive Officer
Galen Centre for Health and Social Policy

With a background in genetics and public health policy, Mr Azrul Mohd Khalib has worked as a development and programme policy specialist for more than 22 years. He has extensive experience working on strategic health system issues related to access to healthcare, sexual reproductive health, HIV and AIDS, gender-based violence, and humanitarian assistance.

Azrul is currently the Founder & Chief Executive Officer of the Galen Centre for Health and Social Policy. His previous positions have been with the Institute for Democracy and Economic Affairs (IDEAS); the International Planned Parenthood Federation (IPPF); representing the Joint United Nations Programme on HIV/AIDS (UNAIDS) under the United Nations Development Programme (UNDP) and the International Committee of the Red Cross (ICRC). Azrul has also worked with the United Nations Children's Fund (UNICEF) and Malaysian AIDS Council.

He is co-founder of the CodeBlue health news website. Azrul is also a board member of the Center to Combat Corruption & Cronyism (C4 Center). He is a writer, has been a columnist with two Malaysian media outlets and is a co-presenter with BFM 89.9ʼs Health & Living programme where he discusses health policy.

Group Chief Executive Officer
Asia OneHealthcare

Dr Chan Boon Kheng has been the Managing Director of Asia OneHealthcare since 2020. He brings over 25 years of experience as a healthcare executive, having worked across Southeast Asia, India, and the Middle East.

Asia OneHealthcare (A1Health) was formed through the merger of Columbia Asia and TE Asia Healthcare, and the acquisition of Ramsay Sime Darby Health Care (RSDH). This integration unites over 30 hospitals across Malaysia, Indonesia, and Vietnam, backed by a collective 40 years of healthcare expertise. A1Healthʼs network spans secondary hospitals, tertiary centres, and specialised facilities, including established facilities such as Columbia Asia, Subang Jaya Medical Centre, Premier Hospitals, and super-specialty centres like CVSKL, ALTY, and Beacon Hospital.

Chief Health Officer
Prudential Assurance Malaysia Berhad
Prudential BSN Takaful Berhad

Ms Manisha Keyal is the Chief Health Officer for Prudential Assurance Malaysia Berhad (PAMB) and Prudential BSN Takaful Berhad (PruBSN). She is leading the companiesʼ health business by developing a sustainable health portfolio, creating innovative products, and strengthening the organisation's presence in the health ecosystem to drive revenue, growth and integrated proposition with distrubution and consumers.

With a distinguished career spanning over two decades, Manisha has extensive experience in leading and managing large scale complex operations, strategy, planning, innovation and transformation programmes and is a strong advocate of continuous improvement culture to achieve superior customer experience and outcomes.

During her career, she has held senior leadership positions in JP Morgan, AIG and AIA, where she has developed and executed innovative growth strategies and integrated ecosystem solutions to deliver unique healthcare offerings to customers.

Manisha firmly believes that doing the right thing the right way leads to the right results. By staying focused and having a clear strategy for execution, she aims to create win-win scenarios. She holds that these values and skills are essential for a successful outcome at work and in life.

She loves to spend her time with her daughter and enjoys practising yoga and being amidst the nature. Recently, she has found her new love for paragliding in the valleys.

Regional Chief Executive Officer
IHH Healthcare North Asia
Chief Executive Officer
Gleneagles Hospital Hong Kong

Dr Kenneth Tsang was appointed as Regional Chief Executive Officer, IHH Healthcare North Asia on 1 April 2024. He leads the development and drives operational and clinical excellence of IHHʼs business operations in North Asia which include multi-specialty hospitals, networks of primary, specialist and surgical clinics, as well as ambulatory care centres in Shanghai and Hong Kong. His strategic leadership plays a pivotal role in advancing IHHʼs integrated healthcare businesses in China towards sustainable and long-term growth.

In conjunction with his regional role, Dr Tsang provides oversight for Gleneagles Hospital Hong Kong as Chief Executive Officer. He also provides leadership for the clinic network under Gleneagles Healthcare, ambulatory services under Gleneagles MediCentre, and Parkway Laboratory Services in Hong Kong. Dr Tsang also spearheads Gleneagles Clinical Trials Centre which contributes to healthcare innovation and advancement in Hong Kong and nearby regions.

Prior to joining IHH, Dr Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician and later in management roles focused on patient safety, strategy and service planning, and infection control.

Dr Tsang is an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong.

Chief Executive Officer
IHH Healthcare Singapore

Dr Peter Chow was appointed as Chief Executive Officer of IHH Singapore on 1 April 2024. He spearheads strategic initiatives and drives operational excellence across IHHʼs business units in Singapore, which include the Gleneagles, Mount Elizabeth, Mount Elizabeth Novena, and Parkway East hospitals, Parkway Shenton Pte Ltd, Parkway MediCentre, IXchange, Parkway Radiology, Parkway Cancer Centre and Parkway Rehab etc.

Dr Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020, where he grew the medical facility as a premier flagship hospital both locally and in the region. He was also awarded the Public Service Medal (Covid-19) and Covid-19 Resilience Medal in 2022 and 2023 respectively for his healthcare leadership role during the pandemic and for supporting various national pandemic efforts in Singapore.

Trained as a dental surgeon with the National University of Singapore, Dr Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. He started his career as a dental officer and subsequently took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare. Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics.

Senior Consultant Clinical Oncologist
Hospital Kuala Lumpur

Chief Executive Officer & Founder
DoctorAnywhere

Lim Wai Mun, Chief Executive Officer and founder of Doctor Anywhere (DA), leads a pioneering tech-driven healthcare company serving over 3.0 million across Southeast Asia. Transitioning from engineering and finance, he founded DA in 2017. Under his leadership,

DA rapidly expanded its comprehensive digital health services and ventured into the insurtech space. Recognised for impressive growth (Financial Times, LinkedIn) and as EY Entrepreneur of the Year, Wai Mun offers invaluable insights into navigating careers at the intersection of technology and healthcare innovation.

Director
Health Transformation Office
Ministry of Health Malaysia

Dr Yap Wei Aun Is currently serving as the Director of the Health Transformation Office within the Ministry of Health.

Prior to rejoining the Ministry of Health, Wei Aun was consulting for the World Bank and the World Health Organization. He also served as the Country Technical Director for the Malaysia Health Systems Research project, a collaboration between the Ministry of Health and Harvard University. His clinical experiences include serving on the frontlines in a variety of hospital and clinic setting—in the United Kingdom, rural Sarawak, and Kuala Lumpur.

Wei Aun received his medical degree (MBBS) from the University of Newcastle Upon Tyne, Master of Public Health (MPH) from Harvard University, and completed his membership exams for admission into the Royal College of Physicians (London).

Group Chief Corporate Officer
IHH Healthcare

Mr Ashok Pandit, appointed as Group Chief Corporate Officer of IHH on 1 April 2024, is responsible for reshaping IHHʼs portfolio to preserve, capitalise and create value-added opportunities in existing and new markets. He oversees corporate functions such as innovation, group strategy, business development, investments, performance management, sustainability, communications and branding and IHH Laboratories, the laboratory network of IHH Healthcare, to ensure the organisationʼs continued success in an ever-evolving healthcare landscape.

Mr Pandit joined IHH in May 2021 as Group Chief Special Projects Officer, with over 28 years of investment banking experience in Asia Pacific. In August 2021, he took on an enlarged portfolio as Group Chief Strategy and Business Development Officer overseeing special projects, business strategy and business development.

Before joining IHH, he was Managing Director, Global Co-Head of Sovereign Wealth and Pension Funds and Head of Financial Sponsor Coverage (Asia Pacific) at Deutsche Bank AG, Singapore. During his 15-year tenure at Deutsche Bank, Mr Pandit held senior investment banking positions, advising leading global institutions and corporations on capital raising, mergers and acquisitions, and advisory and capital restructuring. He led deals that raised over US$100 billion in the capital markets and was a key player in IHHʼs US$2 billion IPO in 2012, which was ranked the worldʼs third largest IPO of the year.

Chief Growth & Innovation Officer
Fortis Healthcare

Dr Ritu Garg is a passionate healthcare professional with extensive leadership experience spanning business strategy, enterprise growth and operations. Currently serving as Chief Growth & Innovation Officer at Fortis Healthcare, she is responsible for driving the revenue engine, digital transformation and innovation at Fortis, with a sharp focus on creating long-term impact and value. She serves on the executive committee and the board of several subsidiaries. She brings a blend of clinical depth, business acumen, and strategic foresight and is passionate about leveraging technology to enhance healthcare delivery and has a deep love for working with people, fostering collaborative environments that drive success.

Regional Partnership Lead for APAC
Google for Health

Mr Jahabar Shalih is responsible for driving Googleʼs focus on health across Asia. Prior to this role, he was leading research partnerships and business development at Fitbit Health Solutions for APAC. Jahabar Shalih has extensive experience in leading and sustaining change programs, commercial management and program management across public and private sectors. At Google, he has worked to build awareness, partnerships and has consulted with organisations across Asia to help them understand the benefits of integrating health focused products and features into programs to improve outcomes, access and efficiency in healthcare.

Subject Matter Expert
Healthcare Advisor
Employees Provident Fund

Mr Suriaghandi a/l P. Suppiah has over 29 yearsʼ experience in business operations, blending a global outlook with a focus on staff development, partnerships, and growth. His expertise spans turnarounds, expansion, investments, and strategic leadership across Healthcare, Investments, Property, and Energy & Utilities sectors. His roles in Malaysia, Asia Pacific, and Europe include positions at Khazanah Nasional Berhad, Pantai Holdings, Parkway Group Healthcare, Salcon Green Energy (UK), KPMG, Pulau Indah Ventures (Khazanah-Temasek JV), and Savills Malaysia.

In 2022, he served as Group Chief Operating Officer of KPJ Healthcare Berhad, having earlier spearheaded its STAR25 Transformation Plan as Chief Transformation Officer, alongside KPJʼs Digitalization and Sustainability roadmaps.

Currently, he is Subject Matter Expert - Healthcare for the Employees Provident Fund, advising on Rakan KKM and healthcare investments, and serves on the National Sports Council Board as Chairman of both the Sports Development as well as Disciplinary Committees.

He holds a BBus (Accounting) from Monash University, an MBA from Chicago Booth, and certifications from Harvard Business School (ASEAN Senior Management Programme) and Stanfordʼs Genovasi Design Thinking School.

An Olympian, he represented Malaysia in hockey at the 1992 Barcelona Olympics.

Head of Global Healthcare
Life Science Practice
Bain & Company

Vikram Kapur is the Head of Bain's Global Healthcare & Life Sciences Practice. Within healthcare, he primarily advises clients in the services, medical technology, biopharma and payer and provider healthcare sectors, with additional expertise in healthcare private equity transactions.

He has more than 20 years of management consulting and operating experience delivering strategies that work for change-oriented business leaders across the Americas, Europe and APAC. Vikram holds deep expertise in strategy development, operational improvement, acquisition due diligence and complex cross-border M&A and integration efforts. He is recognised as a thought leader in the industry and is very active in key industry forums both in the region and globally.

Vikram joined Bain's Chicago office in 2001 and, in addition to Singapore, has spent time working in Bain's Dallas, Stockholm, New York and Hong Kong offices. Vikram received an MBA at the Wharton School at the University of Pennsylvania, an MS in industrial engineering from Northwestern University and a BS in electrical engineering from Case Western Reserve University.

Group Chief Sustainability Officer
IHH Healthcare

Ms Yasemin Tecmen Stubbe leads a team that oversees IHH Healthcare's sustainability strategy anchored on the aspiration to Care for the Good of our Patients, People, Public and Planet.

Yasemin joined IHH more than seven years ago to spearhead and shape the branding strategy of the company before helming the sustainability portfolio.

In addition to spearheading environmental sustainability initiatives across the organisation, she also plays an integral role in overseeing the development and progress of IHHʼs sustainability goals, improving organisational capabilities, and ensuring IHH fulfils its duty as a responsible corporate citizen.

Before joining IHH, she held diverse roles working in leading public relations and advertising agencies in Istanbul to joining Hyatt Hotels headquarters in Chicago after her masterʼs degree from Northwestern University. After moving to Singapore, she continued her Park Hyatt role and formed her own strategic consulting firm where she consulted for other hospitality brands, luxury brands and start-ups. Furthermore, she has taught at Singapore Management University, Lee Kong Chian School of Business.

Chief Executive Officer
Prince Court Medical Centre
IHH Healthcare Malaysia

Dr Shuba Srinivasan is the Chief Executive Officer of Prince Court Medical Centre, where she drives strategic growth, operational transformation and clinical innovation. With over 28 years of healthcare leadership experience, she has championed clinical excellence, governance and sustainable growth across the region.

Previously Vice President of Medical Affairs and Quality at IHH Healthcare Malaysia, Dr Shuba strengthened governance frameworks and led resilience strategies during the Covid-19 pandemic.

At Prince Court, Dr Shuba is advancing digital health, international collaborations and personalised patient services, positioning the hospital as a recognised leader in medical tourism and advanced specialty care.

Under her leadership, Prince Court has earned global recognition such as Worldʼs Best Hospitals and Asiaʼs Top Private Hospitals by Newsweek, achieved ACHS Oncology Centre of Excellence accreditation, introduced pioneering services including Malaysiaʼs first Electric Motorcycle Ambulance, and performed the nationʼs first Endoscopic Sleeve Gastroplasty procedure. She continues to expand strategic partnerships and innovations that elevate patient access, experience and outcomes.

A recognised industry voice, Dr Shuba contributes to regional healthcare dialogues while championing sustainability, innovation and patient-centred models of care. Her leadership philosophy is anchored in purpose-driven innovation and delivering elevated outcomes, ensuring Prince Court remains a destination of choice that is Exclusively Yours, For You, For Life.

Chief Sustainability Officer
UOB Group

Mr Eric Lim is Managing Director and the Chief Sustainability Officer at United Overseas Bank Limited (UOB). His role is to drive UOBʼs sustainability strategy and objectives of helping businesses and individuals transition to a sustainable future and fostering social and environmental well-being among colleagues and communities.

Eric was also the Head of Group Finance from 2013 to 2022, where he was responsible for the Bankʼs core finance functions spanning financial strategy, capital management, regulatory and financial reporting, tax management, business finance and performance management.

Eric holds positions in key UOB management committees, including Chairperson of the Group Sustainability Committee. He is also a member of the Management Committee and the Asset and Liability Committee, and holds directorships in UOB affiliated companies.

Prior to joining UOB, Eric was Managing Director and Head of Wholesale Banking Finance, Singapore and Southeast Asia for Standard Chartered Bank, responsible for driving the strategic partnership between the wholesale business and finance teams. During this time, Eric led the finance functions covering commercial banking, financial markets and investment banking.

Eric began his career with GE Capital where he took on various executive positions in the areas of financial planning and analysis, mergers and acquisitions, audit and controllership. He lived and worked in more than 20 countries, with particular focus in the USA and Japan during that time.

Eric holds a Bachelor of Accountancy from the Nanyang Technological University and an Executive Master of Business Administration from the Kellogg School of Management, Northwestern University.

Regional Climate and Health Manager
Health Care Without Harm - Southeast Asia

Melody Melo-Rijk is a highly regarded expert in the field of climate science with a specialised focus on the intersection of climate change and food security. Mel has worked with WWF, and now with Health Care Without Harm Southeast Asia as Regional Climate and Health Manager, providing invaluable insights into the ways in which climate variability, extreme weather events, and long-term climate trends affect food supply chains, health, and nutrition. Her work in managing various projects has contributed to shaping policies and sustainable practices aimed at mitigating the risks posed by climate change.

In addition to her achievements, Mel speaks frequently on various platforms regarding climate adaptation strategies, helping stakeholders from local communities to international organisations navigate the challenges of maintaining health and food security in a changing climate. Her passion for addressing the complex issues surrounding climate impacts on health and food systems continues to drive forward innovative solutions for a more sustainable and resilient future. She is both a licensed Environmental Planner and a Registered Nutritionist Dietitian, a health professional. Most importantly, her most coveted titles are a wife and a mother.

Senior Vice President
Governance and Sustainability
Bursa Malaysia

Michelle has over 25 years of experience in the Malaysian capital market. She has held various key portfolios in Bursa Malaysia which has provided her with diversified and in-depth knowledge in the space of corporate governance, sustainability, central depository services and information services to name a few.

In her current portfolio, Michelle is also involved in the Advisory Committee on Sustainability Reporting (ACSR), PACE (Policy, Assumptions, Calculators, Education) Working Group, Sustainability Assurance Working Group (SAWG) and the JC3 Sub-Committee 2 on Governance & Disclosure.